Fair Value Measurements - Narrative (Details) - USD ($) $ / shares in Units, shares in Millions |
1 Months Ended | 3 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|---|
May 31, 2022 |
Mar. 31, 2025 |
Sep. 30, 2024 |
Mar. 31, 2024 |
Dec. 31, 2024 |
|
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | |||
| Goodwill impairment charges | $ 0 | ||||
| Investment in securities | |||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
| Shares of investment in securities acquired (in shares) | 8 | ||||
| Common stock, par value (in dollars per share) | $ 0.0001 | ||||
| Aggregate purchase price of acquired investment in securities | $ 80,000,000 | ||||
| Shares of investment in securities sold (in shares) | 8 | ||||
| Consideration for sale of investments in securities | $ 55,000,000 | ||||
| Net gain (loss) recognized from sale of investments in securities | $ 3,000,000 | ||||
| Unrealized losses recognized | $ 3,000,000 | ||||
| X | ||||||||||
- Definition Equity Method Investment, Share Acquired No definition available.
|
| X | ||||||||||
- Definition Equity Securities, Shares Sold No definition available.
|
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of cash outflow to acquire investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of cash inflow from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|